Project Number ARUK-SRF2018A-001 Agency/Funding Organization Alzheimer's Research UK Funding Year 2018 View Full Project Details for Down Syndrome and Alzheimer’s disease: the role of genes other than APP - are cysteine cathepsins a therapeutic target? Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 1. Amyloid beta g. Amyloid beta-Mediated Pathogenesis Researcher and Organization Principal Investigator Frances Wiseman Principal Investigator First Name Frances Principal Investigator Last Name Wiseman Awardee Organization University College London Contact PI Country United Kingdom Project Detail FY Overall Cost $419,517 Funding Organization Agency/Funding Organization Alzheimer's Research UK Funding Organization Country United Kingdom
